Clinical Trial Update: Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating onset of action of ciclesonide nasal spray for seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Ciclesonide nasal spray (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Rhinitis, Allergic, Seasonal, Hay Fever | Phase 3 | Status: COMPLETED